BALTIMORE, MD — An investigative radiotracer used to image neuroendocrine cancer patients who have metastatic tumors can successfully locate their previously elusive primary disease and change ...

Comparison of concurrent chemoradiation with stereotactic body radiation therapy versus conventionally fractionated radiation therapy following induction chemotherapy for unresected locally advanced ...

RESTON, Va. - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for somatostatin receptor PET imaging in neuroendocrine tumors. This AUC is ...

The QUANTM Irradiation System can generate 68 Ga at record breaking levels. (Courtesy: ARTMS Products) Gallium-68 (68 Ga) is a positron emitter that’s becoming established as a valuable diagnostic ...

Advanced Accelerator Applications’ NETSPOT has managed to demonstrate superior efficacy compared to Octreoscan. Advanced Accelerator Applications has been aggressively expanding its network of ...

Since its approval in 2018 by the US Food and Drug Administration, peptide receptor radionuclide therapy (PRRT) has become a mainstay in the treatment of neuroendocrine tumors. Lutetium-177-DOTATATE, ...

BERLIN--(BUSINESS WIRE)--Eckert & Ziegler Radiopharma GmbH has received a recommendation from the European Medicines Agency for approval of its pharmaceutical 68 Ge/ 68 Ga generators. This achievement ...